Healthcare - Biotechnology - NASDAQ - GB
$ 3.62
-25.9 %
$ 2.1 M
Market Cap
-0.05
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--80.06%
EBIT
Estimate
92.78%
Net Income
Estimate
95.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Biodexa Pharmaceuticals Plc
BDRX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BDRX
EBIT FORECAST
EBIT Forecast Chart BDRX
NET INCOME FORECAST
Net Income Chart BDRX